EXE-346

· Exegi Pharma, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EXE-346, covering 2025-02-24 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) [Phase 1, Phase 2]

See pricing